Market Tracker

05/30 10:14am ET

Becton Dickinson and Co (NYSE:BDX)

166.99
Delayed Data
As of May 27
 -0.20 / -0.12%
Today’s Change
128.87
Today|||52-Week Range
169.08
+8.37%
Year-to-Date
3 Stocks I Was Glad to Sell Recently
May 17 / MotleyFool.com - Paid Partner Content
Becton, Dickinson's (BDX) MAX Vaginal Panel Gets CE Mark
May 16 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close167.19
Today’s open167.07
Day’s range166.40 - 167.38
Volume648,605
Average volume (3 months)1,073,311
Market cap$35.4B
Dividend yield1.58%
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-44.07%
Earnings growth (this year)+19.59%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+21.94%
P/E ratio44.7
Price/Sales2.68
Price/Book4.91

Competitors

 Today’s
change
Today’s
% change
BSXBoston Scientific Co...+0.02+0.09%
SYKStryker Corp+0.19+0.17%
ZBHZimmer Biomet Holdin...+0.58+0.47%
EWEdwards Lifesciences...+0.61+0.61%
Data as of 4:04pm ET, 05/27/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$2.21
Annual revenue (last year)$10.3B
Annual profit (last year)$695.0M
Net profit margin6.76%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Vincent A. Forlenza
Chief Financial Officer &
EVP-Administration
Christopher R. Reidy
Corporate headquarters
Franklin Lakes, New Jersey

Forecasts